Atlas Trials

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Clinical trial NCT02792491 · UNKNOWN

Trial details

NCT number
NCT02792491
Sponsor
Pusan National University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2012-08-01
Primary completion
2017-12-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.